Desmoid-type fibromatoses involving the brachial plexus: Treatment options and assessment of c-KIT mutational status

Journal of Neurosurgery

Volumn 104, Issue 5, 2006, Pages 749-756

  Seinfeld, Joshua ^a   Kleinschmidt Demasters, Bette K ^a   Tayal, Shalini ^a   Lillehei, Kevin O ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Desmoid tumor; Immunohistochemical study; Neurofibroma; Neurofibromatosis; Neurofibrosarcoma; Polymerase chain reaction

Indexed keywords

IMATINIB; STEM CELL FACTOR RECEPTOR; TAMOXIFEN;

ABDOMINAL FIBROMATOSIS; ADULT; ARTICLE; BASE PAIRING; BRACHIAL PLEXUS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CASE REPORT; DESMOID TUMOR; FEMALE; GENE MUTATION; HISTOPATHOLOGY; HORMONAL THERAPY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NEUROLOGIC EXAMINATION; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; POLYMERASE CHAIN REACTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL;

ADULT; BASE PAIR MISMATCH; BRACHIAL PLEXUS; BRACHIAL PLEXUS NEUROPATHIES; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DNA MUTATIONAL ANALYSIS; EXONS; FEMALE; FIBROMATOSIS, AGGRESSIVE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PERIPHERAL NERVOUS SYSTEM NEOPLASMS; PIPERAZINES; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS C-KIT; PYRIMIDINES; REOPERATION;

EID: 33646484773     PISSN: 00223085     EISSN: 00223085     Source Type: Journal    
DOI: 10.3171/jns.2006.104.5.749     Document Type: Article

References (32)

1. Amini Nik S, Hohenstein P, Jadidizadeh A, Van Dam K, Bastidas A, Berry RL, et al: Up regulation of Wilms' tumor gene 1 (WT1) in desmoid tumors. Int J Cancer 114:202-208, 2005
2. Brennan MF, Alektiar KM, Maki RG: Soft tissue sarcoma, in DeVita VT, Hellman S, Rosenberg SA (eds): Cancer: Principles and Practice of Oncology, ed 6. Philadelphia: Lipincott, Williams & Wilkins, 2001, Vol 2, p 1850
3. Brooks JJ: Disorders of soft tissue, in Sternberg SS, Antonioli DA, Carter D, et al (eds): Diagnostic Surgical Pathology, ed 2. New York: Raven Press, 1994, pp 147-230
4. Corless CL, Fletcher JA, Heinrich MC: Biology of gastrointestinal stromal tumors. J Clin Oncol 22:3813-3825, 2004
5. Ferah Y, Ayse K, Mustafa C, Ugur S, Murat G, Lale AI: Possible therapeutic role of vitamin D3 in aggressive fibromatosis. Jpn J Clin Oncol 34:472-475, 2004
6. Fletcher CDM (ed): Soft tissue tumors, in Diagnostic Histopathology of Tumors. New York: Churchill Livingstone, 1995, pp 1064-1065
7. Friede RL, Pollak A: Neurosurgical desmoid tumors: presentation of four cases with a review of the differential diagnoses. J Neurosurg 50:725-732, 1979
8. Gaposhkin CG, Bilsky MH, Ginsberg R, Brennan MF: Function-sparing surgery for desmoid tumors and other low-grade fibrosarcomas involving the brachial plexus. Neurosurgery 42:1297-1303, 1998
9. Goldblum J, Fletcher JA: Desmoid-type fibromatoses, in Fletcher CDM, Unni KK, Mertens F (eds): World Health Organization Classification of Tumours : Pathology & Genetics of Tumours of Soft Tissue and Bone. Lyon: IARC Press, 2002, pp 83-84
10. Gonatas NK: Extra-abdominal desmoid tumors. Report of six cases. Arch Pathol 71:214-221, 1961
11. Goy BW, Lee SP, Fu YS, Selch MT, Eilber F: Treatment results of unresected or partially resected desmoid tumors. Am J Clin Oncol 21:584-590, 1998
12. Gronchi A, Casali PG, Mariani L, Lo Vullo S, Colecchia M, Lozza L, et al: Quality of surgery and outcome in extra-abdominal aggressive fibromatosis: a series of patients surgically treated at a single institution. J Clin Oncol 21:1390-1397, 2003
13. Hill DR, Newman H, Phillips TL: Radiation therapy of desmoid tumors. Am J Roentgenol Radiation Ther Nucl Med 117:84-89, 1973
14. Hornick JL, Fletcher CD: Immunohistochemical staining for KIT (CD117) in soft tissue sarcomas is very limited in distribution. Am J Clin Pathol 117:188-193, 2002
15. Miettinen M: Are desmoid tumors KIT positive? Am J Surg Pathol 25:549-550, 2001
16. Mitchell A, Scheithauer BW, Ebersold MJ, Forbes GS: Intracranial fibromatosis. Neurosurgery 29:123-126, 1991
17. Nagata H, Worobec AS, Metcalfe DD: Identification of a polymorphism in the transmembrane domain of the protooncogene c-kit in healthy subjects. Exp Clin Immunogenet 13:210-214, 1996
18. Ng TL, Gown AM, Barry TS, Cheang MC, Chan AK, Turbin DA, et al: Nuclear beta-catenin in mesenchymal tumors. Mod Pathol 18:68-75, 2005
19. Nuyttens JJ, Rust PF, Thomas CR Jr, Thurrisi TA III: Surgery versus radiation therapy for patients with aggressive fibromatosis or desmoid tumors: a comparative review of 22 articles. Cancer 88:1517-1523, 2000
20. Okuno SH, Edmonson JH: Combination chemotherapy for desmoid tumors. Cancer 97:1134-1135, 2003
21. Picariello L, Tonelli F, Brandi ML: Selective oestrogen receptor modulators in desmoid tumours. Expert Opin Investig Drugs 13:1457-1468, 2004
22. Pritchard DJ, Nascimento AG, Peterson IA: Local control of extra-abdominal desmoid tumors. J Bone Joint Surg Am 78:848-854, 1996
23. Quest DO, Salcman M: Fibromatosis presenting as a cranial mass lesion. Case Report. J Neurosurg 44:237-240, 1976
24. Rai AT, Nguyen TP, Hogg JP, Gabriele FJ: Aggressive fibromatosis of the head and neck in a patient with Gardner's syndrome. Neuroradiology 43:650-652, 2001
25. Rosai J (ed): Soft tissues, in Ackerman's Surgical Pathology, ed 8. St. Louis: Mosby, 1996, pp 2021-2034
26. Siegel NS, Bradford CR: Fibromatosis of the head and neck: a challenging lesion. Otolaryngol Head Neck Surg: 123:269-275, 2000
27. Skubitz KM, Skubitz AP: Characterization of sarcomas by means of gene expression. J Lab Clin Med 144:78-91, 2004
28. Stout AP: Juvenile fibromatoses. Cancer 7:953-978, 1954
29. Wilcken N, Tattersall MHN: Endocrine therapy for desmoid tumors. Cancer 68:1384-1388, 1991
30. Yantiss RK, Spiro IJ, Compton CC, Rosenberg AE: Gastrointestinal stromal tumor versus intra-abdominal fibromatosis of the bowel wall: a clinically important differential diagnosis. Am J Surg Pathol 24:947-957, 2000
31. Yarden Y, Kuang WJ, Yang-Feng T, Coussens L, Munemitsu S, Dull TJ, et al: Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J 6:3341-3351, 1987
32. Yildiz F, Kars A, Cengiz M, Yildiz O, Akyurek S, Selek U, et al: 1,25-Dihydroxy vitamin D3: can it be an effective therapeutic option for aggressive fibromatosis. Med Hypotheses 64:333-336, 2005